Lean NAFLD: A not so benign condition?

doi:10.1002/hep4.1143

. 2018 Jan 16;2(1):5-8.

doi: 10.1002/hep4.1143. eCollection 2018 Jan.

Lean NAFLD: A not so benign condition?

Lisa B VanWagner^{1

2}, Matthew J Armstrong^{3

4}

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine Northwestern University Feinberg School of Medicine Chicago IL.
² Department of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL.
³ Liver and Transplant Unit Queen Elizabeth University Hospital Birmingham Birmingham United Kingdom.
⁴ National Institute for Health Research, Birmingham Biomedical Research Centre and Centre for Liver Research University of Birmingham Birmingham United Kingdom.

PMID: 29404505
PMCID: PMC5776877
DOI: 10.1002/hep4.1143

Lean NAFLD: A not so benign condition?

Lisa B VanWagner et al. Hepatol Commun. 2018.

. 2018 Jan 16;2(1):5-8.

doi: 10.1002/hep4.1143. eCollection 2018 Jan.

Authors

Lisa B VanWagner^{1

2}, Matthew J Armstrong^{3

4}

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine Northwestern University Feinberg School of Medicine Chicago IL.
² Department of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL.
³ Liver and Transplant Unit Queen Elizabeth University Hospital Birmingham Birmingham United Kingdom.
⁴ National Institute for Health Research, Birmingham Biomedical Research Centre and Centre for Liver Research University of Birmingham Birmingham United Kingdom.

PMID: 29404505
PMCID: PMC5776877
DOI: 10.1002/hep4.1143

No abstract available

PubMed Disclaimer

Figures

**Figure 1**
Schematic summary of the study by Hagström et al. Abbreviation: SLD, significant liver disease.

See this image and copyright information in PMC

Cited by

Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens).
Ferraioli G. Ferraioli G. J Med Ultrason (2001). 2021 Oct;48(4):489-495. doi: 10.1007/s10396-021-01106-1. Epub 2021 Jun 16. J Med Ultrason (2001). 2021. PMID: 34132934 Free PMC article. Review.
Clinical Factors Associated with Non-Obese Nonalcoholic Fatty Liver Disease Detected among US Adults in the NHANES 2017-2018.
Razouki ZA, Zhang X, Hwang JP, Heredia NI. Razouki ZA, et al. J Clin Med. 2022 Jul 22;11(15):4260. doi: 10.3390/jcm11154260. J Clin Med. 2022. PMID: 35893351 Free PMC article.
Assessing the longitudinal association between the GGT/HDL-C ratio and NAFLD: a cohort study in a non-obese Chinese population.
Xie Q, Lu S, Kuang M, He S, Yu C, Hu C, Zou Y. Xie Q, et al. BMC Gastroenterol. 2022 Dec 5;22(1):500. doi: 10.1186/s12876-022-02598-y. BMC Gastroenterol. 2022. PMID: 36471271 Free PMC article.
Environmental risk factors for liver cancer and nonalcoholic fatty liver disease.
VoPham T. VoPham T. Curr Epidemiol Rep. 2019 Mar;6(1):50-66. doi: 10.1007/s40471-019-0183-2. Epub 2019 Feb 6. Curr Epidemiol Rep. 2019. PMID: 31080703 Free PMC article.
Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials.
Chen JYS, Chua D, Lim CO, Ho WX, Tan NS. Chen JYS, et al. Int J Mol Sci. 2022 Dec 21;24(1):158. doi: 10.3390/ijms24010158. Int J Mol Sci. 2022. PMID: 36613602 Free PMC article. Review.

See all "Cited by" articles

References

1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease‐meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73‐84. - PubMed
1. Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 2012;91:319‐327. - PubMed
1. Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol 2017;67:862‐873. - PubMed
1. Wei JL, Leung JC, Loong TC, Wong GL, Yeung DK, Chan RS, et al. Prevalence and severity of nonalcoholic fatty liver disease in non‐obese patients: a population study using proton‐magnetic resonance spectroscopy. Am J Gastroenterol 2015;110:1306‐1314. - PubMed
1. Sookoian S, Pirola CJ. Systematic review with meta‐analysis: risk factors for non‐alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther 2017;46:85‐95. - PubMed

Grants and funding

K23 HL136891/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease‐meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73‐84. - PubMed

[2] Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease‐meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73‐84. - PubMed

[3] Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 2012;91:319‐327. - PubMed

[4] Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 2012;91:319‐327. - PubMed

[5] Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol 2017;67:862‐873. - PubMed

[6] Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol 2017;67:862‐873. - PubMed

[7] Wei JL, Leung JC, Loong TC, Wong GL, Yeung DK, Chan RS, et al. Prevalence and severity of nonalcoholic fatty liver disease in non‐obese patients: a population study using proton‐magnetic resonance spectroscopy. Am J Gastroenterol 2015;110:1306‐1314. - PubMed

[8] Wei JL, Leung JC, Loong TC, Wong GL, Yeung DK, Chan RS, et al. Prevalence and severity of nonalcoholic fatty liver disease in non‐obese patients: a population study using proton‐magnetic resonance spectroscopy. Am J Gastroenterol 2015;110:1306‐1314. - PubMed

[9] Sookoian S, Pirola CJ. Systematic review with meta‐analysis: risk factors for non‐alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther 2017;46:85‐95. - PubMed

[10] Sookoian S, Pirola CJ. Systematic review with meta‐analysis: risk factors for non‐alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther 2017;46:85‐95. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Lean NAFLD: A not so benign condition?

Affiliations

Lean NAFLD: A not so benign condition?

Authors

Affiliations

Figures

Similar articles

Cited by

References

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources